Synapse - Ashley Regazzi

Search Within

Ashley Regazzi

Results (93)

Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma

Journal Article

Sonpavde, G.; Bellmunt, J.; Rosenberg, J. E.; Regazzi, A. M.; Bajorin, D. F.; Choueiri, T. K.; Qu, A. Q.; Niegisch, G.; Albers, P.; Necchi, A.; more...
Clinical Genitourinary Cancer (2014)

Fulltext@MSK | Save

Gemcitabine-cisplatin (GC) plus radical cystectomy-pelvic lymph node dissection (RC-PLND) for patients (pts) with muscle-invasive bladder cancer (MIBC): Assessing impacts of neoadjuvant chemotherapy (NAC) and the PLND

Meeting Abstract

Tully, C. M.; Bochner, B. H.; Dalbagni, G.; Zabor, E. C.; Herr, H. W.; Donat, S. M.; Ostrovnaya, I.; Regazzi, A. M.; Kim, P. H.; Sfakianos, J. P.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

The high incidence of vascular thromboembolic events (VTE) in advanced urothelial cancer (UC) patients (pts) treated with carboplatin (Cb): Analysis of treatment with gemcitabine (G)/cb (GCb), gcb/bevacizumab (GCbBev), or gemcitabine/cisplatin (GCis)

Meeting Abstract

Tully, C. M.; Apolo, A. B.; Zabor, E. C.; Regazzi, A. M.; Ostrovnaya, I.; Rosenberg, J. E.; Bajorin, D. F.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Impact of prior platinum agent and site of primary in patients with advanced urothelial carcinoma (UC) receiving salvage therapy

Meeting Abstract

Sonpavde, G.; Bellmunt, J.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Choueiri, T. K.; Qu, A. Q.; Niegisch, G.; Albers, P.; Necchi, A.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Impact of number of lines of prior chemotherapy in patients (pts) with advanced urothelial carcinoma (UC) receiving salvage therapy

Meeting Abstract

Sonpavde, G.; Bellmunt, J.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Choueiri, T. K.; Qu, A. Q.; Niegisch, G.; Albers, P.; Necchi, A.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: The role of the host

Journal Article

Gallagher, D. J.; Vijai, J.; Hamilton, R. J.; Ostrovnaya, I.; Iyer, G.; Garcia-Grossman, I. R.; Kim, P. H.; Przybylo, J. A.; Alanee, S.; Riches, J. C.; more...
Annals of Oncology (2013)

Fulltext@MSK | Save

Phase II study of everolimus in metastatic urothelial cancer

Journal Article

Milowsky, M. I.; Iyer, G.; Regazzi, A. M.; Al-Ahmadie, H.; Gerst, S. R.; Ostrovnaya, I.; Gellert, L. L.; Kaplan, R.; Garcia-Grossman, I. R.; Pendse, D.; more...
BJU International (2013)

Fulltext@MSK | Save

Phase ii study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer

Journal Article

Balar, A. V.; Apolo, A. B.; Ostrovnaya, I.; Mironov, S.; Iasonos, A.; Trout, A.; Regazzi, A. M.; Garcia-Grossman, I. R.; Gallagher, D. J.; Milowsky, M. I.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Phase II trial of neoadjuvant gemcitabine (G) and cisplatin (C) with sunitinib in patients (pts) with muscle-invasive bladder cancer (MIBC)

Meeting Abstract

Balar, A. V.; Iyer, G.; Apolo, A. B.; Regazzi, A. M.; Garcia-Grossman, I. R.; Pendse, D.; Ostrovnaya, I.; Chou, J. F.; Bochner, B.; Dalbagni, G.; more...
Journal of Clinical Oncology (2012)

Fulltext@MSK | Save

Single nucleotide polymorphisms as markers of bacillus Calmette-Guerin intravesical therapy response in non-muscle invasive bladder cancer

Meeting Abstract

Alanee, S.; Hamilton, R. J.; Joseph, V.; Ostrovnaya, I.; Garcia-Grossman, I. R.; Gallagher, D. J.; Pendse, D.; Regazzi, A. M.; Przybylo, J. A.; Gaudet, M.; more...
Journal of Clinical Oncology (2012)

Fulltext@MSK | Save